This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
A health-care worker prepares a dose of the Pfizer-BioNTech COVID-19 vaccine at a UHN COVID-19 vaccine clinic in Toronto on Jan. 7, 2021. Nathan Denette/The Canadian Press
OTTAWA—Canada could get more than one million additional doses of COVID-19 vaccine by the end of March through a global vaccine sharing initiative known as COVAX.
But as with most things COVID-19, vaccine-related deliveries are mired in the uncertainty of regulatory reviews and potential production delays.
